Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
The Journal of Experimental Medicine|July 1, 1978
Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitorG R Pasternack, R Snyderman, M C Pike, et al.Cancer Research|October 1, 1993
A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewalL D Walensky, D S Coffey, T H Chen, et al.The Prostate|March 11, 1998
Novel nuclear phosphoprotein pp32 is highly expressed in intermediate- and high-grade prostate cancerS S Kadkol, J R Brody, J I Epstein, et al.Science (New York, N.Y.)|October 15, 1976
Immunotherapy of cancer with antibodyH S Shin, G R Pasternack, J S Economou, et al.The Journal of Experimental Medicine|November 2, 1976
Antibody-mediated suppression of grafted lymphoma. IV. Influence of time of tumor residency in vivo and tumor size upon the effectiveness of suppression by syngeneic antibodyH S Shin, J S Economou, G R Pasternack, et al.The Journal of Biological Chemistry|July 10, 1999
Identification of sequences required for inhibition of oncogene-mediated transformation by pp32J R Brody, S S Kadkol, M A Mahmoud, et al.Cancer|August 5, 1998
Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptorsE S Pizer, S F Lax, F P Kuhajda, et al.Cancer Research|June 15, 1996
Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cellsE S Pizer, C Jackisch, F D Wood, et al.Analytical Biochemistry|March 20, 1995
Simplified high-sensitivity sequencing of a major histocompatibility complex class I-associated immunoreactive peptide using matrix-assisted laser desorption/ionization mass spectrometryA S Woods, A Y Huang, R J Cotter, et al.Cancer Research|March 15, 1996
Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancerE S Pizer, F D Wood, H S Heine, et al.Pageof 4